21 results
424B4
RNAZ
TransCode Therapeutics Inc
19 Jan 24
Prospectus supplement with pricing info
9:57pm
, contractual damages, reputational harm and diminished profits and future earnings.
Although we do not currently have any drugs on the market, if we begin … reassessments, breach of contract and fraud litigation, reputational harm, and other consequences. We have direct or indirect interactions with officials
DRS
187kxzox16h j3b2dx3
29 Jul 22
Draft registration statement
12:00am
10-K
grzaiiv zn0
31 Mar 22
Annual report
11:19am
10-Q
bb5cwc6n gvbm
23 Aug 21
Quarterly report
4:53pm
424B4
vntojyid3 hi
9 Jul 21
Prospectus supplement with pricing info
5:22pm
S-1
mc4lq0b
26 Feb 21
IPO registration
4:06pm
DRS/A
mvaxz sfxxv485
27 Jan 21
Draft registration statement (amended)
12:00am